Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

19 Feb 2016 07:00

RNS Number : 5554P
FastForward Innovations Limited
19 February 2016
 

For immediate release

19 February 2016

FastForward Innovations Limited

("FastForward" or the "Company")

Grant of Options

FastForwardInnovations Limited (AIM: FFWD) announces that, following completion of the recent placings of new shares (raising in aggregate US$12.8 million in January and February 2016), following recommendation by the Remuneration Committee of the Board of Directors, the Board has approved the grant of the following options to Directors ("Options"):

Name

Granted

Number

% of issued shares on fully diluted basis

Exercise Price

 

Lorne Abony

17/02/2016

12,131,548

8%

£0.20

Stephen Dattels

17/02/2016

3,032,887

2%

£0.20

Jim Mellon

17/02/2016

1,516,444

1%

£0.20

TOTAL

16,680,879

11%

Each option entitles the holder upon exercise to one ordinary share of 1p in the capital of the Company ("Ordinary Shares").Following the grant of the Options, 50 per cent.of the Options shall vest immediately, 25 per cent. of the Options shall vest after 12 months (subject to the weighted average price of the Company's ordinary shares rising above £0.25 for ten consecutive trading days), and the balance of 25 per cent. shall vest after 24 months (subject to the weighted average price of the Company's ordinary shares rising above £0.35 for ten consecutive trading days). Subject to vesting (which is accelerated in the event of a change of control), the Options may only be exercised while the party remains, or in the six month period after they cease to be, an "eligible employee" of the Company (as such term is defined in the Option Agreements) and within a five year term from the date of grant. The Options may be exercised on a cash-less basis subject to agreement of the Board at such time.

Following grant of the Options, FastForward has 17,535,910 shares under option representing 11.6 per cent.of its issued share capital (on a fully diluted basis).

Related Party Transaction

The grant of the Options to the Directorsrepresents a related party transaction under Rule 13 of the AIM Rules.

Accordingly, Mr Ian Burns and Mr Bryan Smith are the independent directors of the Company for the purposes of the grant of the Options, and each confirms that, having consulted with the Company's Nominated Adviser, the terms of the Options, and the respective awards of such Options to the Directors are fair and reasonable insofar as the Company's shareholders are concerned. In particular the Independent Directors noted that the exercise price of the Options is a 33 per cent. premium to the recent fundraising of the Company at £0.15, and the vesting conditions attached to 50 per cent. of the Options fully incentivise the management and leadership to create shareholder value over the next 24 months.

Mr Mellon, who chairs the Remuneration Committee, commented:"The Company has not previously granted any options to Directors having raised funds at 3.32p, 5p, 8p, and most recently 15p per share. Now that the Company is on a sound financial footing, it is the right time to properly incentivise the Company's management, and in particular Mr Abony as Chief Executive Officer. All of the Board, and recent investor group, have enormous faith in Mr Abony and this option package, at a premium to the current share price and 33% premium to the last funding round, with material vesting performance hurdles, aligns Mr Abony's interests absolutely with shareholders and provides significant incentive for him to deliver real shareholder growth."

For further information please visit www.fstfwd.coor contact:

James Biddle/ Michael Cornish (Nomad)

Beaumont Cornish LimitedTel: +44 207 628 3396

 

Peterhouse Corporate Finance Limited

Guy Miller/ Lucy Williams

Tel: +44 (0) 207 469 0930

Elysium Fund Management Limited

PO Box 650

1st Floor

Royal Chambers

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: elysium@elysiumfundman.com

 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForwardInnovations Limited. There can be no assurance that such statements will prove to be accurate, achievable or recognisable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForwardInnovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQKLBFQLFBBBQ
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.